|
|
|
Insider
Information: |
Sato Vicki L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,670,897 |
|
Indirect Shares
|
8,084 |
|
|
Direct
Value |
$40,918,225 |
|
|
Indirect Value
|
$3,617,833 |
|
|
Total
Shares |
1,678,981 |
|
|
Total
Value |
$44,536,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-15 |
116,369 |
2017-12-12 |
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
227 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
135,917 |
|
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2004-04-27 |
4 |
A |
$19.91 |
$60,009 |
D/D |
3,014 |
11,212 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
President |
|
2004-05-06 |
4 |
A |
$0.01 |
$875 |
D/D |
87,500 |
188,108 |
|
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2005-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,020 |
14,232 |
|
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2006-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,770 |
17,002 |
|
- |
|
INFI |
Infinity Pharmaceuticals ... |
Director |
|
2006-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,051 |
11,051 |
|
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2007-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,114 |
21,116 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,740 |
24,856 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2009-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,790 |
30,646 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,544 |
38,527 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2012-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
42,107 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2013-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,263 |
45,370 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2014-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
47,743 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2014-04-30 |
4 |
A |
$61.40 |
$114,993 |
D/D |
1,873 |
1,873 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2015-04-29 |
4 |
A |
$60.95 |
$115,003 |
D/D |
1,887 |
3,777 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2015-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,033 |
26,776 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2016-04-27 |
4 |
A |
$39.29 |
$123,001 |
D/D |
3,131 |
6,930 |
0 |
- |
|
PKI |
Perkinelmer Inc |
Director |
|
2016-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,194 |
29,970 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2017-04-26 |
4 |
A |
$41.13 |
$123,005 |
D/D |
2,991 |
9,921 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2017-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
137,500 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2018-04-25 |
4 |
A |
$52.91 |
$130,000 |
D/D |
2,457 |
12,378 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2019-04-24 |
4 |
A |
$43.55 |
$129,997 |
D/D |
2,985 |
15,404 |
0 |
- |
|
BWA |
Borgwarner Inc |
Director |
|
2020-04-29 |
4 |
A |
$29.67 |
$130,014 |
D/D |
4,382 |
19,823 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
1,657,310 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
136,163 |
0 |
- |
|
227 Records found
|
|
Page 1 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|